Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing

  • Ingra M. Claro
  • , Mariana S. Ramundo
  • , Thais M. Coletti
  • , Camila A.M. da Silva
  • , Ian N. Valenca
  • , Darlan S. Candido
  • , Flavia C.S. Sales
  • , Erika R. Manuli
  • , Jaqueline G. de Jesus
  • , Anderson de Paula
  • , Alvina Clara Felix
  • , Pamela dos Santos Andrade
  • , Mariana C. Pinho
  • , William M. Souza
  • , Mariene R. Amorim
  • , José Luiz Proenca-Modena
  • , Esper G. Kallas
  • , José Eduardo Levi
  • , Nuno Rodrigues Faria
  • , Ester C. Sabino
  • Nicholas J. Loman, Joshua Quick

Producción científica: Articlerevisión exhaustiva

31 Citas (Scopus)

Resumen

Emerging and re-emerging viruses are a global health concern. Genome sequencing as an approach for monitoring circulating viruses is currently hampered by complex and expensive methods. Untargeted, metagenomic nanopore sequencing can provide genomic information to identify pathogens, prepare for or even prevent outbreaks. SMART (Switching Mechanism at the 5′ end of RNA Template) is a popular approach for RNA-Seq but most current methods rely on oligo-dT priming to target polyadenylated mRNA molecules. We have developed two random primed SMART-Seq approaches, a sequencing agnostic approach ‘SMART-9N’ and a version compatible rapid adapters  available from Oxford Nanopore Technologies ‘Rapid SMART-9N’. The methods were developed using viral isolates, clinical samples, and compared to a gold-standard amplicon-based method. From a Zika virus isolate the SMART-9N approach recovered 10kb of the 10.8kb RNA genome in a single nanopore read. We also obtained full genome coverage at a high depth coverage using the Rapid SMART-9N, which takes only 10 minutes and costs up to 45% less than other methods. We found the limits of detection of these methods to be 6 focus forming units (FFU)/mL with 99.02% and 87.58% genome coverage for SMART-9N and Rapid SMART-9N respectively. Yellow fever virus plasma samples and SARS-CoV-2 nasopharyngeal samples previously confirmed by RT-qPCR with a broad range of Ct-values were selected for validation. Both methods produced greater genome coverage when compared to the multiplex PCR approach and we obtained the longest single read of this study (18.5 kb) with a SARS-CoV-2 clinical sample, 60% of the virus genome using the Rapid SMART-9N method. This work demonstrates that SMART-9N and Rapid SMART-9N are sensitive, low input, and long-read compatible alternatives for RNA virus detection and genome sequencing and Rapid SMART-9N improves the cost, time, and complexity of laboratory work.

Idioma originalEnglish
Número de artículo241
PublicaciónWellcome Open Research
Volumen6
DOI
EstadoPublished - 2023

Nota bibliográfica

Publisher Copyright:
Copyright: © 2023 Claro IM et al.

Financiación

This work was supported by a Medical Research Council-São Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) (https://caddecentre.org); FAPESP/Newton Funds (FAPESP 2017/08012-9), Bill & Melinda Gates Foundation (INV-034540 and INV-034652), and I.M.C (FAPESP 2018/17176-8). M.S.R. is supported by the Faculdade de Medicina da Universidade de São Paulo (FMUSP). T.M.C. (2019/07544-2), C.A.M.S. (2019/21301-5), F.C.S.S. (2018/25468-9), J.G.J. (2018/17176-8, 2019/12000-1, 18/14389-0) and E.C.S (2018/14389-0) are supported by FAPESP. P.S.A. is supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (88887.596940/2021-00). W.M.S is supported by FAPESP (2017/13981-0, 2019/24251-9), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (408338/2018-0), and the National Institutes of Health (AI120942). D.S.C is supported by the Clarendon Fund and by the Department of Zoology, University of Oxford. M.R.A is supported by CAPES (88887.356527/2019-00). N.R.F. is supported by a Wellcome Trust Royal Society Sir Henry Dale Fellowship (204311). N.J.L. and J.Q. are supported by the Wellcome ARTIC network (206298).

FinanciadoresNúmero del financiador
Wellcome ARTIC network
Medical Research Council-São Paulo Research Foundation
Wellcome Trust Royal Society Sir Henry Dale Fellowship204311
National Institutes of Health (NIH)AI120942
Newton Fund2017/08012-9
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior88887.596940/2021-00, 2017/13981-0, 2019/24251-9
Clarendon Fund88887.356527/2019-00
Bill and Melinda Gates Foundation2018/17176-8, INV-034540, INV-034652
Faculdade de Medicina da Universidade de São Paulo2018/14389-0, 2019/21301-5, 2018/25468-9, 2019/07544-2, 2019/12000-1
Conselho Nacional de Desenvolvimento Científico e Tecnológico408338/2018-0
Fundação de Amparo à Pesquisa do Estado de São Paulo18/14389-0, MR/S0195/1
Wellcome Trust206298

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Medicine (miscellaneous)
    • General Biochemistry, Genetics and Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing'. En conjunto forman una huella única.

    Citar esto